25 XP   0   0   10

Ipsen SA ADR
Buy, Hold or Sell?

Let's analyse Ipsen together

PenkeI guess you are interested in Ipsen SA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ipsen SA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ipsen SA ADR

I send you an email if I find something interesting about Ipsen SA ADR.

Quick analysis of Ipsen (30 sec.)










What can you expect buying and holding a share of Ipsen? (30 sec.)

How much money do you get?

How much money do you get?
$0.64
When do you have the money?
1 year
How often do you get paid?
82.1%

What is your share worth?

Current worth
$12.33
Expected worth in 1 year
$15.48
How sure are you?
82.1%

+ What do you gain per year?

Total Gains per Share
$3.78
Return On Investment
12.6%

For what price can you sell your share?

Current Price per Share
$30.06
Expected price per share
$28.62 - $32.66
How sure are you?
50%

1. Valuation of Ipsen (5 min.)




Live pricePrice per Share (EOD)

$30.06

2. Growth of Ipsen (5 min.)




Is Ipsen growing?

Current yearPrevious yearGrowGrow %
How rich?$4b$3.2b$595.1m15.4%

How much money is Ipsen making?

Current yearPrevious yearGrowGrow %
Making money$343.7m$259.5m$84.2m24.5%
Net Profit Margin20.5%10.9%--

How much money comes from the company's main activities?

3. Financial Health of Ipsen (5 min.)




What can you expect buying and holding a share of Ipsen? (5 min.)

Welcome investor! Ipsen's management wants to use your money to grow the business. In return you get a share of Ipsen.

What can you expect buying and holding a share of Ipsen?

First you should know what it really means to hold a share of Ipsen. And how you can make/lose money.

Speculation

The Price per Share of Ipsen is $30.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ipsen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ipsen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $12.33. Based on the TTM, the Book Value Change Per Share is $0.79 per quarter. Based on the YOY, the Book Value Change Per Share is $0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ipsen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.454.8%1.043.5%0.521.7%0.441.5%0.351.2%
Usd Book Value Change Per Share1.364.5%0.792.6%0.471.6%0.351.2%0.441.5%
Usd Dividend Per Share0.000.0%0.160.5%0.080.3%0.110.4%0.110.4%
Usd Total Gains Per Share1.364.5%0.953.1%0.551.8%0.471.6%0.551.8%
Usd Price Per Share29.48-30.05-26.28-25.28-27.35-
Price to Earnings Ratio5.09-8.62-13.04-10.16-47.58-
Price-to-Total Gains Ratio21.74-39.43-82.57-82.42-82.80-
Price to Book Ratio2.39-2.59-2.69-3.34-7.42-
Price-to-Total Gains Ratio21.74-39.43-82.57-82.42-82.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share30.06
Number of shares33
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.160.11
Usd Book Value Change Per Share0.790.35
Usd Total Gains Per Share0.950.47
Gains per Quarter (33 shares)31.2215.44
Gains per Year (33 shares)124.8961.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
121104115154752
2422072403094114
36431136545141176
48541549060187238
510651861575234300
612762274089281362
7148726865104328424
8170830990119375486
91919331115134422548
1021210371240149468610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.00.00.0100.0%10.00.00.0100.0%16.02.00.088.9%26.02.00.092.9%26.02.00.092.9%
Book Value Change Per Share2.00.00.0100.0%6.00.04.060.0%9.01.08.050.0%14.03.011.050.0%14.03.011.050.0%
Dividend per Share1.00.01.050.0%7.00.03.070.0%13.00.05.072.2%23.00.05.082.1%23.00.05.082.1%
Total Gains per Share2.00.00.0100.0%9.00.01.090.0%15.01.02.083.3%23.03.02.082.1%23.03.02.082.1%

Fundamentals of Ipsen

About Ipsen SA ADR

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.

Fundamental data was last updated by Penke on 2024-04-22 12:05:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Ipsen SA ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ipsen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 28.2% means that $0.28 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ipsen SA ADR:

  • The MRQ is 28.2%. The company is making a huge profit. +2
  • The TTM is 20.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.2%TTM20.5%+7.8%
TTM20.5%YOY10.9%+9.6%
TTM20.5%5Y9.3%+11.2%
5Y9.3%10Y11.0%-1.7%
1.1.2. Return on Assets

Shows how efficient Ipsen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.1% Return on Assets means that Ipsen generated $0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ipsen SA ADR:

  • The MRQ is 7.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.1%TTM5.2%+1.9%
TTM5.2%YOY4.5%+0.7%
TTM5.2%5Y3.7%+1.5%
5Y3.7%10Y3.7%0.0%
1.1.3. Return on Equity

Shows how efficient Ipsen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.7% Return on Equity means Ipsen generated $0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ipsen SA ADR:

  • The MRQ is 11.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.7%TTM8.7%+3.0%
TTM8.7%YOY8.0%+0.8%
TTM8.7%5Y6.9%+1.8%
5Y6.9%10Y7.0%-0.1%

1.2. Operating Efficiency of Ipsen SA ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ipsen is operating .

  • Measures how much profit Ipsen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 29.6% means the company generated $0.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ipsen SA ADR:

  • The MRQ is 29.6%. The company is operating very efficient. +2
  • The TTM is 31.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ29.6%TTM31.4%-1.8%
TTM31.4%YOY18.9%+12.5%
TTM31.4%5Y21.2%+10.2%
5Y21.2%10Y21.2%0.0%
1.2.2. Operating Ratio

Measures how efficient Ipsen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.70 means that the operating costs are $0.70 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ipsen SA ADR:

  • The MRQ is 0.704. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.686. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.704TTM0.686+0.018
TTM0.686YOY0.311+0.375
TTM0.6865Y0.474+0.212
5Y0.47410Y0.625-0.151

1.3. Liquidity of Ipsen SA ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ipsen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.17 means the company has $1.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ipsen SA ADR:

  • The MRQ is 1.167. The company is just able to pay all its short-term debts.
  • The TTM is 1.098. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.167TTM1.098+0.069
TTM1.098YOY1.840-0.742
TTM1.0985Y1.329-0.231
5Y1.32910Y1.305+0.024
1.3.2. Quick Ratio

Measures if Ipsen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.86 means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ipsen SA ADR:

  • The MRQ is 0.864. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.768. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.864TTM0.768+0.096
TTM0.768YOY1.063-0.296
TTM0.7685Y0.833-0.066
5Y0.83310Y0.823+0.010

1.4. Solvency of Ipsen SA ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ipsen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ipsen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.40 means that Ipsen assets are financed with 39.5% credit (debt) and the remaining percentage (100% - 39.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ipsen SA ADR:

  • The MRQ is 0.395. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.418. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.418-0.023
TTM0.418YOY0.435-0.017
TTM0.4185Y0.503-0.085
5Y0.50310Y0.496+0.008
1.4.2. Debt to Equity Ratio

Measures if Ipsen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 65.3% means that company has $0.65 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ipsen SA ADR:

  • The MRQ is 0.653. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.721. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.653TTM0.721-0.068
TTM0.721YOY0.773-0.052
TTM0.7215Y1.055-0.334
5Y1.05510Y1.015+0.040

2. Market Valuation of Ipsen SA ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ipsen generates.

  • Above 15 is considered overpriced but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 5.09 means the investor is paying $5.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ipsen SA ADR:

  • The EOD is 5.187. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.087. Based on the earnings, the company is cheap. +2
  • The TTM is 8.623. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.187MRQ5.087+0.100
MRQ5.087TTM8.623-3.536
TTM8.623YOY13.040-4.417
TTM8.6235Y10.160-1.537
5Y10.16010Y47.584-37.424
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ipsen SA ADR:

  • The EOD is 7.313. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.172. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.058. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.313MRQ7.172+0.141
MRQ7.172TTM7.058+0.114
TTM7.058YOY1.304+5.754
TTM7.0585Y1.074+5.984
5Y1.07410Y0.690+0.384
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ipsen is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Ipsen SA ADR:

  • The EOD is 2.437. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.390. Based on the equity, the company is underpriced. +1
  • The TTM is 2.590. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.437MRQ2.390+0.047
MRQ2.390TTM2.590-0.200
TTM2.590YOY2.692-0.103
TTM2.5905Y3.344-0.754
5Y3.34410Y7.424-4.080
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ipsen SA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.3560.786+73%0.470+189%0.355+282%0.440+208%
Book Value Per Share--12.33311.655+6%9.856+25%7.914+56%6.682+85%
Current Ratio--1.1671.098+6%1.840-37%1.329-12%1.305-11%
Debt To Asset Ratio--0.3950.418-5%0.435-9%0.503-21%0.496-20%
Debt To Equity Ratio--0.6530.721-9%0.773-15%1.055-38%1.015-36%
Dividend Per Share---0.161-100%0.080-100%0.113-100%0.106-100%
Eps--1.4491.039+39%0.523+177%0.437+232%0.347+318%
Free Cash Flow Per Share--1.0281.065-4%1.285-20%1.138-10%1.138-10%
Free Cash Flow To Equity Per Share--0.2530.362-30%0.682-63%0.469-46%0.469-46%
Gross Profit Margin--1.000-0.138+114%0.317+215%0.422+137%0.174+474%
Market Cap9944388599.040+2%9752514168.3209941080419.200-2%8692986870.064+12%8361498060.708+17%9047871862.400+8%
Net Profit Margin--0.2820.205+38%0.109+160%0.093+204%0.110+156%
Operating Margin--0.2960.314-6%0.189+56%0.212+39%0.212+39%
Operating Ratio--0.7040.686+3%0.311+127%0.474+48%0.625+13%
Pb Ratio2.437+2%2.3902.590-8%2.692-11%3.344-29%7.424-68%
Pe Ratio5.187+2%5.0878.623-41%13.040-61%10.160-50%47.584-89%
Price Per Share30.060+2%29.48030.050-2%26.277+12%25.275+17%27.350+8%
Price To Free Cash Flow Ratio7.313+2%7.1727.058+2%1.304+450%1.074+568%0.690+939%
Price To Total Gains Ratio22.164+2%21.73639.429-45%82.567-74%82.418-74%82.796-74%
Quick Ratio--0.8640.768+13%1.063-19%0.833+4%0.823+5%
Return On Assets--0.0710.052+38%0.045+58%0.037+94%0.037+94%
Return On Equity--0.1170.087+34%0.080+48%0.069+69%0.070+68%
Total Gains Per Share--1.3560.946+43%0.550+147%0.468+190%0.547+148%
Usd Book Value--4079994600.0003855657850.000+6%3260458575.000+25%2618216455.556+56%2210364359.891+85%
Usd Book Value Change Per Share--1.3560.786+73%0.470+189%0.355+282%0.440+208%
Usd Book Value Per Share--12.33311.655+6%9.856+25%7.914+56%6.682+85%
Usd Dividend Per Share---0.161-100%0.080-100%0.113-100%0.106-100%
Usd Eps--1.4491.039+39%0.523+177%0.437+232%0.347+318%
Usd Free Cash Flow--339946200.000352323400.000-4%106273200.000+220%62763311.111+442%40347842.857+743%
Usd Free Cash Flow Per Share--1.0281.065-4%1.285-20%1.138-10%1.138-10%
Usd Free Cash Flow To Equity Per Share--0.2530.362-30%0.682-63%0.469-46%0.469-46%
Usd Market Cap9944388599.040+2%9752514168.3209941080419.200-2%8692986870.064+12%8361498060.708+17%9047871862.400+8%
Usd Price Per Share30.060+2%29.48030.050-2%26.277+12%25.275+17%27.350+8%
Usd Profit--479296400.000343787400.000+39%259521075.000+85%197581725.000+143%166543560.331+188%
Usd Revenue--1697490300.0001668521250.000+2%806918750.000+110%920915844.444+84%867432421.487+96%
Usd Total Gains Per Share--1.3560.946+43%0.550+147%0.468+190%0.547+148%
 EOD+4 -4MRQTTM+22 -14YOY+24 -125Y+25 -1110Y+25 -11

3.2. Fundamental Score

Let's check the fundamental score of Ipsen SA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.187
Price to Book Ratio (EOD)Between0-12.437
Net Profit Margin (MRQ)Greater than00.282
Operating Margin (MRQ)Greater than00.296
Quick Ratio (MRQ)Greater than10.864
Current Ratio (MRQ)Greater than11.167
Debt to Asset Ratio (MRQ)Less than10.395
Debt to Equity Ratio (MRQ)Less than10.653
Return on Equity (MRQ)Greater than0.150.117
Return on Assets (MRQ)Greater than0.050.071
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Ipsen SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.701
Ma 20Greater thanMa 5029.603
Ma 50Greater thanMa 10029.069
Ma 100Greater thanMa 20028.949
OpenGreater thanClose30.060
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets6,322,900
Total Liabilities2,499,100
Total Stockholder Equity3,825,100
 As reported
Total Liabilities 2,499,100
Total Stockholder Equity+ 3,825,100
Total Assets = 6,322,900

Assets

Total Assets6,322,900
Total Current Assets1,898,400
Long-term Assets4,424,500
Total Current Assets
Cash And Cash Equivalents 528,400
Short-term Investments 10,600
Net Receivables 866,000
Inventory 289,500
Other Current Assets 214,500
Total Current Assets  (as reported)1,898,400
Total Current Assets  (calculated)1,909,000
+/- 10,600
Long-term Assets
Property Plant Equipment 574,600
Goodwill 663,900
Intangible Assets 3,342,700
Long-term Assets  (as reported)4,424,500
Long-term Assets  (calculated)4,581,200
+/- 156,700

Liabilities & Shareholders' Equity

Total Current Liabilities1,626,800
Long-term Liabilities872,300
Total Stockholder Equity3,825,100
Total Current Liabilities
Short-term Debt 121,500
Short Long Term Debt 9,000
Accounts payable 771,400
Other Current Liabilities 728,200
Total Current Liabilities  (as reported)1,626,800
Total Current Liabilities  (calculated)1,630,100
+/- 3,300
Long-term Liabilities
Long-term Liabilities Other 247,300
Long-term Liabilities  (as reported)872,300
Long-term Liabilities  (calculated)247,300
+/- 625,000
Total Stockholder Equity
Common Stock83,800
Retained Earnings 644,400
Accumulated Other Comprehensive Income 3,726,500
Other Stockholders Equity -629,600
Total Stockholder Equity (as reported)3,825,100
Total Stockholder Equity (calculated)3,825,100
+/-0
Other
Capital Stock83,800
Cash and Short Term Investments 528,400
Common Stock Shares Outstanding 83,511
Current Deferred Revenue5,700
Liabilities and Stockholders Equity 6,322,900
Net Debt -65,500
Net Invested Capital 3,834,100
Net Working Capital 271,600
Short Long Term Debt Total 462,900



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-31
> Total Assets 
1,576,868
1,705,475
1,678,194
1,675,500
1,633,391
1,635,400
1,561,088
1,571,437
1,565,332
1,629,800
1,713,300
1,760,800
1,938,000
2,253,000
2,423,500
2,423,500
2,967,000
2,967,000
225,758
3,072,000
2,552,079
3,295,500
3,377,400
3,377,400
4,804,600
4,804,600
4,306,900
4,306,900
0
4,229,800
0
4,317,200
0
4,521,500
0
5,006,800
0
5,507,100
0
5,607,900
0
6,090,600
6,322,900
6,322,9006,090,60005,607,90005,507,10005,006,80004,521,50004,317,20004,229,80004,306,9004,306,9004,804,6004,804,6003,377,4003,377,4003,295,5002,552,0793,072,000225,7582,967,0002,967,0002,423,5002,423,5002,253,0001,938,0001,760,8001,713,3001,629,8001,565,3321,571,4371,561,0881,635,4001,633,3911,675,5001,678,1941,705,4751,576,868
   > Total Current Assets 
652,362
610,592
639,778
624,500
632,750
584,800
606,349
651,888
601,845
651,400
671,600
672,600
809,900
964,000
1,050,400
1,050,400
925,300
925,300
74,694
1,016,400
913,963
1,180,200
1,185,600
1,185,600
1,221,400
1,221,400
1,346,500
1,346,500
1,411,100
1,411,100
1,578,800
1,578,800
1,764,300
1,764,200
1,953,800
1,953,800
2,589,000
2,589,000
2,397,600
2,397,600
0
1,759,800
1,898,400
1,898,4001,759,80002,397,6002,397,6002,589,0002,589,0001,953,8001,953,8001,764,2001,764,3001,578,8001,578,8001,411,1001,411,1001,346,5001,346,5001,221,4001,221,4001,185,6001,185,6001,180,200913,9631,016,40074,694925,300925,3001,050,4001,050,400964,000809,900672,600671,600651,400601,845651,888606,349584,800632,750624,500639,778610,592652,362
       Cash And Cash Equivalents 
218,584
167,263
178,118
159,600
145,007
84,800
113,641
121,207
130,958
131,900
186,300
92,900
226,100
377,600
425,500
425,500
200,600
200,600
16,755
228,000
278,247
359,300
344,500
344,500
213,200
213,200
353,300
353,300
0
430,000
0
642,500
0
737,500
0
814,700
0
1,068,300
0
1,169,300
0
413,400
528,400
528,400413,40001,169,30001,068,3000814,7000737,5000642,5000430,0000353,300353,300213,200213,200344,500344,500359,300278,247228,00016,755200,600200,600425,500425,500377,600226,10092,900186,300131,900130,958121,207113,64184,800145,007159,600178,118167,263218,584
       Short-term Investments 
1,162
88
49
600
9
1,100
516
1,587
150
100
100
6,100
6,800
4,200
0
6,600
0
12,100
0
29,600
0
16,500
600
5,500
50,900
53,300
59,300
59,300
0
57,700
0
48,900
0
0
0
42,400
0
46,100
0
31,000
0
24,700
10,600
10,60024,700031,000046,100042,40000048,900057,700059,30059,30053,30050,9005,50060016,500029,600012,10006,60004,2006,8006,1001001001501,5875161,100960049881,162
       Net Receivables 
279,071
273,612
286,545
285,900
298,500
303,500
0
386,210
336,021
339,400
379,900
381,200
445,700
389,200
472,700
494,500
445,200
445,200
40,176
591,500
385,580
497,900
582,700
510,700
602,100
602,100
667,800
720,000
569,600
569,700
652,000
559,800
736,200
765,100
764,500
877,400
772,000
1,258,900
673,700
673,700
0
685,600
866,000
866,000685,6000673,700673,7001,258,900772,000877,400764,500765,100736,200559,800652,000569,700569,600720,000667,800602,100602,100510,700582,700497,900385,580591,50040,176445,200445,200494,500472,700389,200445,700381,200379,900339,400336,021386,2100303,500298,500285,900286,545273,612279,071
       Inventory 
102,970
108,083
112,149
116,100
117,834
121,600
127,857
133,434
121,463
108,000
105,500
107,800
107,400
112,700
113,300
113,300
152,200
152,200
12,302
167,400
145,822
188,300
198,500
198,500
197,200
197,200
214,000
214,000
220,900
220,900
213,900
213,900
232,700
232,700
219,400
219,400
190,100
190,100
284,100
284,100
0
350,000
289,500
289,500350,0000284,100284,100190,100190,100219,400219,400232,700232,700213,900213,900220,900220,900214,000214,000197,200197,200198,500198,500188,300145,822167,40012,302152,200152,200113,300113,300112,700107,400107,800105,500108,000121,463133,434127,857121,600117,834116,100112,149108,083102,970
       Other Current Assets 
50,575
61,546
62,917
62,300
71,400
73,800
364,335
9,450
13,253
72,000
-200
84,600
23,900
80,300
22,500
10,500
127,300
115,200
3,777
-100
104,313
118,200
29,800
126,400
158,000
155,600
27,800
-100
138,300
132,800
34,200
113,700
14,400
28,900
87,200
-100
492,300
25,600
270,500
239,500
0
286,100
214,500
214,500286,1000239,500270,50025,600492,300-10087,20028,90014,400113,70034,200132,800138,300-10027,800155,600158,000126,40029,800118,200104,313-1003,777115,200127,30010,50022,50080,30023,90084,600-20072,00013,2539,450364,33573,80071,40062,30062,91761,54650,575
   > Long-term Assets 
924,506
1,094,883
1,038,416
1,051,000
1,000,641
1,050,600
954,739
919,549
963,487
978,400
1,041,700
1,088,200
1,128,100
1,288,900
0
1,373,100
0
2,041,700
0
2,055,600
0
2,115,300
0
2,191,800
0
3,583,200
0
2,960,400
0
2,818,800
0
2,738,400
0
2,757,300
0
3,053,000
0
2,918,100
0
3,210,300
0
4,330,800
4,424,500
4,424,5004,330,80003,210,30002,918,10003,053,00002,757,30002,738,40002,818,80002,960,40003,583,20002,191,80002,115,30002,055,60002,041,70001,373,10001,288,9001,128,1001,088,2001,041,700978,400963,487919,549954,7391,050,6001,000,6411,051,0001,038,4161,094,883924,506
       Property Plant Equipment 
249,972
264,186
282,287
275,200
271,728
291,700
281,781
275,446
287,483
296,000
309,600
336,900
348,700
350,600
379,000
379,000
382,500
382,800
30,762
418,900
331,139
427,700
474,300
474,500
664,500
664,700
679,300
679,300
654,200
654,200
646,600
646,600
645,700
645,700
647,500
647,500
585,900
585,900
581,400
581,400
0
571,600
574,600
574,600571,6000581,400581,400585,900585,900647,500647,500645,700645,700646,600646,600654,200654,200679,300679,300664,700664,500474,500474,300427,700331,139418,90030,762382,800382,500379,000379,000350,600348,700336,900309,600296,000287,483275,446281,781291,700271,728275,200282,287264,186249,972
       Goodwill 
290,236
306,541
299,105
290,700
0
304,000
298,198
299,270
310,720
312,300
324,600
336,800
353,400
350,000
357,200
357,100
396,700
396,700
28,587
389,100
303,647
392,100
395,600
395,600
622,500
622,400
632,600
632,700
0
627,500
0
592,900
0
604,500
0
623,100
0
557,300
0
579,900
0
681,000
663,900
663,900681,0000579,9000557,3000623,1000604,5000592,9000627,5000632,700632,600622,400622,500395,600395,600392,100303,647389,10028,587396,700396,700357,100357,200350,000353,400336,800324,600312,300310,720299,270298,198304,0000290,700299,105306,541290,236
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,000
37,000
175,800
175,800
12,184
13,401
131,108
128,394
173,600
173,600
171,100
171,100
111,400
111,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000111,400111,400171,100171,100173,600173,600128,394131,10813,40112,184175,800175,80037,00037,00000000000000000
       Intangible Assets 
236,967
264,073
166,538
182,700
0
142,000
129,175
112,364
144,787
142,400
160,600
105,700
151,200
326,800
380,100
380,100
899,000
899,000
68,359
930,100
746,225
963,600
1,011,900
1,012,000
1,949,700
1,949,600
1,383,200
1,382,900
0
1,247,300
0
1,121,300
0
1,142,500
0
1,391,900
0
1,373,000
0
1,585,400
0
2,547,900
3,342,700
3,342,7002,547,90001,585,40001,373,00001,391,90001,142,50001,121,30001,247,30001,382,9001,383,2001,949,6001,949,7001,012,0001,011,900963,600746,225930,10068,359899,000899,000380,100380,100326,800151,200105,700160,600142,400144,787112,364129,175142,0000182,700166,538264,073236,967
       Long-term Assets Other 
20,746
42,793
81,692
81,100
93,988
112,800
11,553
12,465
9,440
8,400
8,700
20,600
15,700
14,900
0
13,300
0
18,200
0
34,400
0
21,200
0
9,700
0
60,300
0
64,000
0
63,100
0
52,500
0
4,800
0
58,300
0
50,700
0
37,200
0
95,500
-613,200
-613,20095,500037,200050,700058,30004,800052,500063,100064,000060,30009,700021,200034,400018,200013,300014,90015,70020,6008,7008,4009,44012,46511,553112,80093,98881,10081,69242,79320,746
> Total Liabilities 
592,520
628,772
598,964
600,500
617,966
580,300
634,837
631,786
591,593
647,000
645,400
626,200
712,400
994,900
1,061,300
1,061,300
1,559,000
1,559,000
112,886
1,536,100
1,260,513
1,627,700
1,534,000
1,534,000
2,821,300
2,821,300
2,553,900
2,553,900
0
2,370,400
0
2,195,400
0
2,133,200
0
2,252,800
0
2,441,000
0
2,271,200
0
2,687,300
2,499,100
2,499,1002,687,30002,271,20002,441,00002,252,80002,133,20002,195,40002,370,40002,553,9002,553,9002,821,3002,821,3001,534,0001,534,0001,627,7001,260,5131,536,100112,8861,559,0001,559,0001,061,3001,061,300994,900712,400626,200645,400647,000591,593631,786634,837580,300617,966600,500598,964628,772592,520
   > Total Current Liabilities 
308,007
295,925
332,373
347,900
370,410
335,700
436,963
372,939
376,241
350,600
410,200
374,300
461,500
432,700
561,300
561,300
921,600
921,600
69,212
941,800
816,541
1,054,400
959,100
959,200
1,669,800
1,669,800
1,452,500
1,452,500
1,334,900
1,334,900
1,213,100
1,213,100
1,117,000
1,117,000
1,228,400
1,228,400
1,374,200
1,374,200
1,335,400
1,335,400
0
1,709,800
1,626,800
1,626,8001,709,80001,335,4001,335,4001,374,2001,374,2001,228,4001,228,4001,117,0001,117,0001,213,1001,213,1001,334,9001,334,9001,452,5001,452,5001,669,8001,669,800959,200959,1001,054,400816,541941,80069,212921,600921,600561,300561,300432,700461,500374,300410,200350,600376,241372,939436,963335,700370,410347,900332,373295,925308,007
       Short-term Debt 
17,183
7,160
4,190
10,400
4,176
4,600
4,353
7,608
9,603
6,900
10,100
9,100
16,100
22,100
375,100
7,000
870,100
122,400
20,107
64,700
21,684
18,500
0
37,700
0
828,400
600,100
285,100
0
307,800
0
231,700
0
191,900
0
35,300
0
59,900
0
3,800
0
1,200
121,500
121,5001,20003,800059,900035,3000191,9000231,7000307,8000285,100600,100828,400037,700018,50021,68464,70020,107122,400870,1007,000375,10022,10016,1009,10010,1006,9009,6037,6084,3534,6004,17610,4004,1907,16017,183
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
375,100
375,100
870,100
870,100
20,107
22,114
21,684
21,235
167,700
167,700
819,900
828,400
600,100
285,100
0
277,000
0
2,800
0
161,800
0
5,500
0
30,600
0
3,800
0
1,200
9,000
9,0001,20003,800030,60005,5000161,80002,8000277,0000285,100600,100828,400819,900167,700167,70021,23521,68422,11420,107870,100870,100375,100375,10000000000000000
       Accounts payable 
122,647
120,168
140,671
130,400
149,805
141,100
159,799
138,296
154,848
148,400
179,800
172,500
195,100
194,700
241,500
241,500
264,100
264,100
23,450
319,100
251,839
325,200
379,800
379,800
394,200
394,200
508,500
508,500
475,800
475,800
495,200
495,200
518,600
518,600
594,700
594,700
577,800
577,800
647,100
647,100
0
746,600
771,400
771,400746,6000647,100647,100577,800577,800594,700594,700518,600518,600495,200495,200475,800475,800508,500508,500394,200394,200379,800379,800325,200251,839319,10023,450264,100264,100241,500241,500194,700195,100172,500179,800148,400154,848138,296159,799141,100149,805130,400140,671120,168122,647
       Other Current Liabilities 
157,338
155,248
173,085
151,400
181,345
157,300
66,142
47,021
38,003
166,800
35,600
176,500
43,300
170,600
121,700
50,700
219,600
190,800
11,626
79,300
247,657
270,800
192,600
269,600
289,900
246,100
122,700
244,100
147,700
66,500
110,800
439,600
89,700
345,900
210,700
339,800
240,400
729,600
582,100
679,300
0
544,600
728,200
728,200544,6000679,300582,100729,600240,400339,800210,700345,90089,700439,600110,80066,500147,700244,100122,700246,100289,900269,600192,600270,800247,65779,30011,626190,800219,60050,700121,700170,60043,300176,50035,600166,80038,00347,02166,142157,300181,345151,400173,085155,248157,338
   > Long-term Liabilities 
284,513
332,847
266,591
252,600
247,556
244,600
197,874
258,847
215,352
296,400
235,200
251,900
250,900
562,200
0
500,000
0
637,400
0
594,300
0
573,300
0
574,800
0
1,151,500
0
1,101,400
0
1,035,500
0
982,300
0
1,016,200
0
1,024,400
0
1,066,800
0
935,800
0
977,500
872,300
872,300977,5000935,80001,066,80001,024,40001,016,2000982,30001,035,50001,101,40001,151,5000574,8000573,3000594,3000637,4000500,0000562,200250,900251,900235,200296,400215,352258,847197,874244,600247,556252,600266,591332,847284,513
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185,200
185,200
205,200
205,200
14,257
15,680
148,997
145,912
188,900
188,900
422,600
422,600
246,700
246,700
354,900
354,900
220,700
220,700
245,000
245,000
252,200
252,200
268,200
268,200
268,800
268,800
0
0
0
000268,800268,800268,200268,200252,200252,200245,000245,000220,700220,700354,900354,900246,700246,700422,600422,600188,900188,900145,912148,99715,68014,257205,200205,200185,200185,20000000000000000
> Total Stockholder Equity
982,624
1,074,978
1,077,190
1,072,800
1,012,837
1,053,200
924,214
937,364
971,499
980,300
1,065,200
1,132,000
1,222,500
1,255,100
1,358,900
1,358,900
1,398,100
1,398,100
112,100
1,525,400
1,289,631
1,665,300
1,841,100
1,841,100
1,981,300
1,981,300
1,751,000
1,751,000
0
1,857,100
0
2,119,100
0
2,386,600
0
2,751,500
0
3,064,500
0
3,337,300
0
3,404,300
3,825,100
3,825,1003,404,30003,337,30003,064,50002,751,50002,386,60002,119,10001,857,10001,751,0001,751,0001,981,3001,981,3001,841,1001,841,1001,665,3001,289,6311,525,400112,1001,398,1001,398,1001,358,9001,358,9001,255,1001,222,5001,132,0001,065,200980,300971,499937,364924,2141,053,2001,012,8371,072,8001,077,1901,074,978982,624
   Common Stock
84,128
84,176
84,196
84,200
84,227
84,300
84,255
84,123
84,243
82,800
82,900
83,100
83,200
83,300
83,600
83,600
83,600
83,600
6,151
83,700
64,896
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
83,800
0
83,800
83,800
83,80083,800083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80083,80064,89683,7006,15183,60083,60083,60083,60083,30083,20083,10082,90082,80084,24384,12384,25584,30084,22784,20084,19684,17684,128
   Retained Earnings 
156,584
75,525
95,271
91,700
424
90,200
-29,491
96,230
152,540
104,000
153,500
90,100
189,900
133,000
225,900
225,900
125,900
125,900
20,011
272,300
152,947
197,500
389,500
389,500
220,100
220,100
-50,700
-50,700
221,900
221,900
548,000
548,000
304,000
304,000
646,600
646,600
394,300
394,300
648,600
648,600
0
195,200
644,400
644,400195,2000648,600648,600394,300394,300646,600646,600304,000304,000548,000548,000221,900221,900-50,700-50,700220,100220,100389,500389,500197,500152,947272,30020,011125,900125,900225,900225,900133,000189,90090,100153,500104,000152,54096,230-29,49190,20042491,70095,27175,525156,584
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
741,912
915,277
897,723
896,900
928,186
878,700
869,450
757,011
734,716
793,500
828,800
958,800
949,400
1,038,800
381,700
1,049,400
521,600
1,188,600
37,803
1,169,400
561,450
1,384,000
689,400
1,367,800
993,800
910,000
1,048,500
720,100
1,499,200
-169,700
1,467,100
-527,800
1,977,000
-282,200
2,021,900
-647,400
2,566,400
-374,300
57,500
-633,500
0
-159,000
-629,600
-629,600-159,0000-633,50057,500-374,3002,566,400-647,4002,021,900-282,2001,977,000-527,8001,467,100-169,7001,499,200720,1001,048,500910,000993,8001,367,800689,4001,384,000561,4501,169,40037,8031,188,600521,6001,049,400381,7001,038,800949,400958,800828,800793,500734,716757,011869,450878,700928,186896,900897,723915,277741,912



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,127,500
Cost of Revenue-778,700
Gross Profit2,348,8002,348,800
 
Operating Income (+$)
Gross Profit2,348,800
Operating Expense-1,699,900
Operating Income648,900648,900
 
Operating Expense (+$)
Research Development619,300
Selling General Administrative217,800
Selling And Marketing Expenses917,100
Operating Expense1,699,9001,754,200
 
Net Interest Income (+$)
Interest Income-
Interest Expense-26,200
Other Finance Cost-28,300
Net Interest Income-54,500
 
Pretax Income (+$)
Operating Income648,900
Net Interest Income-54,500
Other Non-Operating Income Expenses-
Income Before Tax (EBT)761,500536,300
EBIT - interestExpense = 622,700
780,600
670,600
Interest Expense26,200
Earnings Before Interest and Taxes (EBIT)648,900787,700
Earnings Before Interest and Taxes (EBITDA)945,500
 
After tax Income (+$)
Income Before Tax761,500
Tax Provision-136,200
Net Income From Continuing Ops619,900625,300
Net Income644,400
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses2,478,600
Total Other Income/Expenses Net112,60054,500
 

Technical Analysis of Ipsen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ipsen. The general trend of Ipsen is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ipsen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ipsen SA ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 32.07 < 32.66 < 32.66.

The bearish price targets are: 29.80 > 29.80 > 28.62.

Tweet this
Ipsen SA ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ipsen SA ADR. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ipsen SA ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ipsen SA ADR. The current macd is 0.28270363.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ipsen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ipsen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ipsen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ipsen SA ADR Daily Moving Average Convergence/Divergence (MACD) ChartIpsen SA ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ipsen SA ADR. The current adx is 11.60.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ipsen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Ipsen SA ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ipsen SA ADR. The current sar is 29.37.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ipsen SA ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ipsen SA ADR. The current rsi is 55.70. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Ipsen SA ADR Daily Relative Strength Index (RSI) ChartIpsen SA ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ipsen SA ADR. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ipsen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ipsen SA ADR Daily Stochastic Oscillator ChartIpsen SA ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ipsen SA ADR. The current cci is 55.11.

Ipsen SA ADR Daily Commodity Channel Index (CCI) ChartIpsen SA ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ipsen SA ADR. The current cmo is 12.82.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ipsen SA ADR Daily Chande Momentum Oscillator (CMO) ChartIpsen SA ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ipsen SA ADR. The current willr is -43.88349515.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ipsen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ipsen SA ADR Daily Williams %R ChartIpsen SA ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ipsen SA ADR.

Ipsen SA ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ipsen SA ADR. The current atr is 0.41378377.

Ipsen SA ADR Daily Average True Range (ATR) ChartIpsen SA ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ipsen SA ADR. The current obv is 126.00.

Ipsen SA ADR Daily On-Balance Volume (OBV) ChartIpsen SA ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ipsen SA ADR. The current mfi is 51.85.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ipsen SA ADR Daily Money Flow Index (MFI) ChartIpsen SA ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ipsen SA ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Ipsen SA ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ipsen SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.701
Ma 20Greater thanMa 5029.603
Ma 50Greater thanMa 10029.069
Ma 100Greater thanMa 20028.949
OpenGreater thanClose30.060
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ipsen with someone you think should read this too:
  • Are you bullish or bearish on Ipsen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ipsen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ipsen SA ADR

I send you an email if I find something interesting about Ipsen SA ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Ipsen SA ADR.

Receive notifications about Ipsen SA ADR in your mailbox!